EL MONTE, Calif., Aug. 14, 2017 /PRNewswire/ -- Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine, handicraft products made from yew timber and yew candle and soap made with yew essence oil in China, today reported financial results for three- and six-months ended June 30, 2017.
Total revenues for the second quarter of 2017 decreased 2.84% to $15.6 million from $16.1 million a year ago. Sales of TCM raw materials amounted to 73.93% of total revenues; sales of handicrafts amounted to 0.01% of total revenues and sales of "Others" segment consisting with the yew candles, pine needle extracts, essential oil soaps and dietary supplement amounted to 26.06% of total revenues.
Total revenues for the second quarter of 2017 decreased 2.84% to $15.6 million from $16.1 million a year ago. Sales of TCM raw materials amounted to 73.93% of total revenues; sales of handicrafts amounted to 0.01% of total revenues and sales of "Others" segment consisting with the yew candles, pine needle extracts, essential oil soaps and dietary supplement amounted to 26.06% of total revenues.
